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Background: The ketoisovalerate reductase (EC 1.2.7.7 ) is required for the formation of beauvericin via the
nonribosomal peptide synthetase biosynthetic pathway. It catalyzes the NADPH-specific reduction of ketoisovaleric
acid to hydroxyisovalerate. However, little is known about the bioinformatics’ data about the 2-Kiv reductase in
Fusarium. To date, heterologous production of the gene KivRFp from Fusarium has not been achieved.
Results: The KivRFp gene was subcloned and expressed in Escherichia coli BL21 using the pET expression system.
The gene KivRFp contained a 1,359 bp open reading frame (ORF) encoding a polypeptide of 452 amino acids with
a molecular mass of 52 kDa. Sequence analysis indicated that it showed 61% and 52% amino acid identities to
ketoisovalerate reductase from Beauveria bassiana ATCC 7159 (ACI30654) and Metarhizium acridum CQMa 102
(EFY89891), respectively; and several conserved regions were identified, including the putative nucleotide-binding
signature site, GXGXXG, a catalytic triad (Glu405, Asn184, and Lys285). The KivRFp exhibited the highest activity at
35°C and pH 7.5 respectively, by reduction of ketoisovalerate. It also exhibited the high level of stability over wide
temperature and pH spectra and in the presence of metal ions or detergents.
Conclusions: A new ketoisovalerate reductase KivRFp was identified and characterized from the
depsipeptide-producing fungus F. proliferatum. KivRFp has been shown to have useful properties, such as moderate
thermal stability and broad pH optima, and may serve as the starting points for future protein engineering and
directed evolution, towards the goal of developing efficient enzyme for downstream biotechnological applications.
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Cyclooligomer depsipeptides (CODs) are a prominent
class of bioactive peptides produced from various Fungi
by large multimeric enzyme complexes called nonriboso-
mal peptide synthetases (NRPSs). There are many
reports about CODs which contain various hydroxyl
acids, such as D-hydroxyisovalerate (D-Hiv); examples
include the beauvericin [1], enniatins [2], destruxin [3],
bassianolide [4], fusafungine [5]. Beauvericin, produced
by certain fungi of Beauveria [1], Isaria [6] and Fusar-
ium [7] that exhibits insecticidal, displays antimicrobial,* Correspondence: zhanglixin@im.ac.cn
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reproduction in any medium, provided the oranti-tumor activities, reverses multidrug resistance in
Candida albicans [8-11]. Its molecular structure consists
of an alternating sequence of three N-methyl-L-phenyl-
alanine and three D-hydroxyisovaleric acids (Figure 1)
[12]. Thus, the hydroxyl acid is a key intermediate in the
formation of the beauvericin.
In mammals, the catabolism of the branched-chain
amino acids (BCAAs) leucine, isoleucine, and valine pro-
ceeds by two-step process, i.e. transamination step (ami-
notransfer) and oxidation step. BCAAs are usually
transaminated to form 2-keto acids by branched-chain
amino acid transaminases (BCATs). These 2-keto acids
are oxidatively decarboxylated by mitochondrial branched-
chain 2-ketoacid dehydrogenase [13-15] and converted to
acyl CoA. However, in some fungal species, namely the
hydroxysiovalerate-containing CODs producers, there is an-
other pathway leading from L-Val to D-Hiv via the ketoLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Overall mechanism of beauvericin biosynthesis in Fusarium species.
Table 1 Starting bacterial strains and plasmids used in
this study
Strain or plasmid Description Source
Strains





E. coli BL21(DE3) F–, ompT, hsdSB (rB–, mB–),




Wild strain, producing beauvericin
isolated from marine sample
This study
E. coli TOP10-KivRFp Positive clone of artificial gene
synthesis, which carries the
KivRFp gene fragment
This study




pUCE Cloning vector; Apr Inovogen
pET28a Expression vector; Kmr Novagen
pUCE-KivRFp pUCE, which carries the complete
ketoisovalerate reductase (KivRFp)
This study





Apr, ampicillin resistant; Kmr, kanamycin resistant.
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lyzes the reversible reduction of 2-ketoisovalertate (2-Kiv),
the intermediate of branched-chain amino acid metabolism
[16], to D-Hiv in the presence of NADPH, which cannot be
replaced by NADH [17-19]. So far, D-HivDH has been
purified and partially characterized exclusively from the
enniatin producer, Fusarium sambucinum [17,19], but the
corresponding protein and gene sequences were not
determined. Xu et al., demonstrated the novel kivr-en-
coding 2-ketoisovalerate reductase is the sole supplier of
D-Hiv for both beauvericin and bassianolide biosynthesis
in Beauveria bassiana ATCC 7159 [20].
On the other hand, little is known about the bioinfor-
matics’ data about the 2-Kiv reductase (2-KivR) in Fusar-
ium, thus warranting further study. To date, heterologous
production of the gene KivRFp from Fusarium has not
been achieved; similarly, very little information is available
about the role of the KivRFp in the regulation of beauver-
icin biosynthesis. In order to get a closer insight into the
unique and intriguing features of the ketoisovalerate re-
ductase in the Fusarium genus, we undertook both gen-
etic and biochemical studies. In the present article, we
describe the identification and functional analysis of the
KivRFp of Fusarium proliferatum LF061. Our report
demonstrates that the KivRFp constituted a new member
of family ketonate oxidoreductases.
Methods
Chemicals
Chemicals were of the highest purity commercially avail-
able. Pyruvate, 2-Kiv, 2-ketovalerate, 2-ketoglutarate and
2-ketobutyrate were obtained from TCI Japan Ltd. D-Hiv
were purchased from Sigma. NADH, NADPH, NADP+
were products of Roche.
Bacterial strains, plasmids, and culture
The starting strains and plasmids used in this study are
listed in Table 1. E. coli was grown at 37°C in Luria–Bertani
(LB) medium supplemented with appropriate antibiotics
[21]. When required, ampicillin was added at a final con-
centration of 100 μg/mL, kanamycin at 25 μg/mL, and
chloramphenicol, at 12.5 μg/mL. Fusarium proliferatum
LF061 (deposited in China General MicrobiologicalCulture Collection under the accession number of
CGMCC 3.1777) was maintained on potato dextrose agar
(PDA).
DNA preparation and manipulation
E. coli cells were transformed by the calcium chloride
procedure [21]. Recombinant plasmid DNA was isolated
by the method of Birnboim and Doly [22]. For sequen-
cing, this DNA was further purified by polyethylene gly-
col precipitation [21]. Restriction enzymes, T4 DNA
ligase and calf intestinal alkaline phosphatase were pur-
chased from New England Biolabs (Ipswich, USA) or
Takara (Tokyo, Japan) and used according to the manu-
facturers’ instructions. BugBuster Ni-NTA His. Bind
Purification Kit was purchased from Novagen (Code No.
NV70751-3, Novagen).
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Deduced amino acid sequences of 13 ketonate reductases
or homologous proteins were subjected to protein phylo-
genetic analysis. A phylogenetic tree was generated using
the neighbor joining method of Saitou and Nei [23] with
MEGA 4.0 software [24]. A total of 4 sequences were
aligned with the CLUSTAL_W program [25] and visually
examined with BoxShade Server program. The length of
each branch pair represents the evolutionary distance
between the sequences.
Heterologous expression of gene KivRFp and purification
of recombinant KivRFp
Artificial gene synthesis was finished by Innovogen
Tech. Co. (Beijing, China). Jcat (Java Codon Adaptation
Tool) [26] and OPTIMIZER [27] were used to improve
heterologous protein production. The integrity of the
nucleotide sequence of all newly constructed plasmids
was confirmed by DNA sequencing. The primer pairs
with restriction enzyme sites for HindIII and NdeI were
designed to generate an N-terminal His-tag of the re-
combinant ketonate reductase. The modified KivRFp
gene was cloned into an expression vector, pET28a (+)
and the recombinant plasmid pKivRFp-His was trans-
formed into E. coli BL21 (DE3) cells. When the cell
density at 600 nm reached around 0.6, expression of re-
combinant KivRFp protein was initiated by addition of
0.6 mM isopropylthio-β-D-galactoside and continued
cultivation for additional 6 h at 20°C. Cells were har-
vested by centrifugation at 6,000 × g for 5 min, washed
twice with ice-cold 50 mM sodium phosphate buffer
(pH 8.0) and resuspended in the same buffer containing
10 mM imidazole, disrupted by sonification in an ice-
water bath (60 times, 5 s). Recombinant KivRFp reduc-
tase was applied to metal-chelating chromatography
using Ni-NTA affinity chromatography (Novagen)
according to the manufacturer’s instructions.
Polyacrylamide gel electrophoresis of enzyme in the
presence of sodium dodecyl sulfate (SDS) was carried
out by the method of Sambrook and Russell [21]. Pro-
tein concentrations were determined by a modified
Bradford procedure with bovine serum albumin as a
standard [28].
Enzyme assays
The standard 2-Kiv reductase assay mixture contained
50 mM sodium phosphate buffer (pH 7.0), 0.7 mM 2-Kiv,
0.29 mM NADPH, and enzyme in a final volume of
3.0 mL. The reaction was initiated by the addition of sub-
strate, and the decrease in absorbance at 340 nm (A340)
was measured at 35°C, which was performed using an
UNICO 2802 UV/VIS spectrophotometer. A molar ex-
tinction coefficient of 6.22 cm2/pmol NADPH was used
for the calculation of enzyme activity. One unit wasdefined as the amount of enzyme caused the oxidation of
1 μmol of NADPH per min. The reaction mixture for
the assay of the reverse reaction contained 50 mM so-
dium phosphate buffer (pH 8.0), 2.8 mM NADP+,
5.7 mM D-Hiv, and enzyme in a final volume of
3.0 mL. The increase in the rate of reduction of NADP+
due to oxidation of D-Hiv was measured at 340 nm
(45°C) [18,19,29].Characterization of recombinant KivRFp and biochemical
properties
The purified KivRFp was subjected to a series of bio-
chemical analysis, including determine the pH optimum,
temperature optimum, and effects of various detergents
and metal ions. All measurements were carried out in
triplicate. The values were the mean of the data. The
substrate specificity of the purified KivRFp protein was
performed using the following substrates: pyruvate,
2-Kiv, 2-ketovalerate, 2-ketobutyrate, 2-ketocapronate
and 2-ketoglutarate.
The optimum temperature of purified KivRFp was
determined by assaying reductase activities in a 50 mM
sodium phosphate buffer (pH 8.0) for a temperature
range of 25-65°C, in which 2-Kiv (0.7 mM) acted as sub-
strate. Optimal pH was determined by examining the
activity of the enzyme after incubation at 40°C for
10 min using 2-Kiv (0.7 mM) as substrate. The buffers
used were: 50 mM sodium phosphate buffer (pH 5.0-8.0),
50 mM Tris–HCl buffer (pH 8.0-10.5).
Various metal ions (CoCl2, CaCl2, ZnCl2, MgCl2,
K2SO4, FeSO4, CuCl2, MnCl2, and FeCl3), and chelating
agent EDTA at final concentrations of 5 mM were added
to the enzyme in 50 mM sodium phosphate buffer (pH
8.0), that was assayed for 2-Kiv reductase activity follow-
ing preincubation at 40°C. Effect of detergents on reduc-
tase activity was determined by incubating the enzyme
for 10 min at 40°C in 50 mM sodium phosphate buffer
(pH 8.0), containing Tween-20, Tween-80, Triton X-100,
β-mercaptoethanol, sodium dodecyl sulfate (SDS), cetyl-
trimethyl ammonium bromide (CTAB), diethylpyrocar-
bonate (DEPC), phenylmethanesulfonyl fluoride (PMSF),
dimethyl sulfoxide (DMSO). The concentrations of
metal ions, EDTA, detergents, and surfactants used were
5 mM, 3 mM, and 0.5% (v/v), respectively. The activity
of the enzyme preparation in the absence of metal ions
and detergents before incubation was defined as the
100% level.Nucleotide sequence accession number
The DNA sequence of KivRFp from Fusarium prolifera-
tum LF061 was deposited in GenBank under accession
number of JQ922252.
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Cloning and sequence analysis of KivRFp
We have recently cloned and functionally characterized
beauvericin biosynthetic locus (bea) of the F. prolifera-
tum LF061 genome (unpublished data). The FpBEAS
gene encoding the beauvericin synthetase was found to
be clustered with a gene (KivRFp) encoding a deduced
putative 2-ketoisovalerate reductase (KivRFp). Amino
acid sequence alignment indicated that KivRFp exhibited
low identity with other ketopantoate reductases or hypo-
thetical proteins in GenBank. KivRFp shared the highest
sequence identity with the KIVR from B. bassiana
ATCC 7159 (ACI30654, 61% identity/75% similarity),
followed by the putative 2-ketopantoate reductase from
Metarhizium acridum CQMa 102 (EFY89891, 56% iden-
tity/70% similarity). Similarity was also detected with the
hypothetical or putative 2-dehydropantoate reductasesFigure 2 Conserved sequence blocks from multiple sequence alignme
proteins. Sequences alignment was carried out with CLUSTALW [25] and B
XP_382715, hypothetical protein from Gibberella zeae PH-1; ACI30654, ketoi
ketopantoate reductase from E. coli. The alignment was optimized and ann
use of the determined crystal structure of PanE (2OFP, chain A). Identical am
mentioned in the text are labeled with arrows and numbered with referen
hinge region separating the N-terminal Rossmann fold and the C-terminalfrom Gibberella zeae PH-1 (anamorph: F. graminearum)
and F. oxysporum Fo5176 (EGU84839, 49% identity; and
EGU75687, 47% identity, respectively), and also with
functionally uncharacterized terminal reductase domain
of the Xylaria sp. bassianolide synthetase (ABR28366,
30% identity/48% similarity).
Various ketonate reductases contain the conserved
GXGXXG nucleotide-binding signature. And also, a con-
served glutamate (Glu), an asparagines (Asn) and a lysine
(Lys), together constituting a catalytic triad [30,31]. The
amino acid sequence alignment to other ketonate reduc-
tases retrieved from GenBank, identified the conserved
motifs, including the putative GXGXXG nucleotide-
binding signature and a Glu-Asn-Lys triad active site
architecture (Figure 2). Thus, KivRFp probably uses a
catalytic triad consisting of the glutamate (Glu405), the
asparagine (Asn184) and the highly conserved lysinent of KivRFp from Fusarium proliferatum LF061 and other related
oxShade Server (http://www.ch.embnet.org/software/BOX_form.html).
sovalerate reductase from Beauveria bassiana ATCC 7159; P0A9J4, PanE
otated with secondary structure predictions in SWISS-MODEL [32] by
ino acids are shown on black ground. Key amino acid residues
ce to the PanE sequence. The nucleotide binding signatures and the
catalytic domain in PanE are boxed [30,33].









Figure 4 SDS-polyacrylamide gel of overexpressed
ketoisovalerate reductase KivRFp in E. coli. Lane M: molecular
weight protein marker (TransGen, Cat. No: DR301); lane 1, induced
culture of E. coli/pET28a: total protein extract, as negative control;
lane 2, total protein extract, induced culture of E. coli/ pKivRFp-His;
lane 3: purified KivRFp (52 kDa).
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in the F. proliferatum KivRFp that might contribute to
the formation of the active hole and involve directly in
the catalytic process [30,31]. Furthermore, to clarify
the phylogenetic relationship of the KivRFp with other
ketonate reductases, a neighbor joining phylogenetic
tree was constructed using the amino acid sequence of
the ketonate reductive enzymes. As shown in Figure 3.
In this tree, KivRFp formed a distinct group with the
KIVR of B. bassiana ATCC7159 (ACI30654), which is
located closest to the branch of putative 2-ketopantoate re-
ductase of Metarhizium acridum CQMa 102 (EFY89891),
hypothetical protein of Trichoderma virens Gv29-8 and
Cordyceps militaris CM01 (accession number EHK17663
and EGX96948 respectively). Moreover, KivRFp showed
sequence and the structural similarity with ketopanto-
ate reductases [32,33], but not with D-lactose or
D-hydroxyisocaproate dehydrogenase [20]. These
results suggest that the KivRFp is a new member of
family ketonate reductases.
Expression and purification of recombinant KivRFp
To investigate the property of this KivRFp, optimized
KivRFp gene was expressed as an N-terminal His-tag
fusion protein using pET-28a (+) expression system in
E. coli BL21(DE3). The recombinant protein was ana-
lyzed by SDS-PAGE and Coomassie brilliant blue stain-
ing (Figure 4). These results indicate that recombinant
KivRFp protein is expressed (Mw, about 52 kDa), as
which correlated well to the predicted full length of
KivRFp. The purity of the purified protein was more
than 98% according to SDS–PAGE analysis.
Substrate and cofactor specificity of KivRFp
We expressed KivRFp as a hexahistidine-tagged (His-
tagged) protein and investigated its substrate specificity.
The enzyme exhibited the highest activity towards 2-Kiv
as substrate, while the homologues compounds 2-keto-
valerate, pyruvate, 2-ketocapronate, 2-ketoglutarate andFigure 3 Phylogenetic analysis of KivRFp and closely related proteins
[23,24]. Except for KivRFp, the protein sequences for dehydrogenase were r
node indicate the bootstrap percentages of 1000 resamples.2-ketobutyrate were shown to be poor substrates
(Figure 5A). And also, the KivRFp showed higher coen-
zyme specificity with respect to NADPH than NADH
(Figure 5B), which is a little different from highly specific
D-hydroxyisovalerate dehydrogenase from enniatin pro-
ducer F. sambucinum.
Effect of temperature and pH on KivRFp
Reduction of 2-Kiv activity of KivRFp was determined
from 25°C to 65°C. The purified KivRFp showed highest
activity at 35°C. However, the activity of KivRFp reduced
quickly above 55°C (Figure 6). Thermostability analysis
showed that KivRFp was not stable and lost activity in
less than 10 min at 60°C (data not shown). And also, the
reductase showed activity in a rather broader pH range
of 6.5-9.5. Maximal activity was observed at pH 7.5 and. Phylogenetic analysis was performed using the program MEGA4.0
etrieved from GenBank (http://www.ncbi.nlm.nih.gov). The numbers at
Figure 5 Substrate specificity of overexpressed and purified ketoisovalerate reductase KivRFp. 5A). Specific activity of reductive reaction
of different homologous compounds using NADPH (0.29 mM) as coenzyme. 2-ketoisovalerate (2-Kiv), 2-ketovalerate (2-Kva), pyruvate,
2-ketocapronate (2-Kca), 2-ketoglutarate (2-Kgl), and 2-ketobutyrate (2-Kbu). 5B). Specific activity of reductive reaction of different coenzymes
using 2-Kiv (0.7 mM) as substrate. Relative activity was shown as the percentage of the activity of the activity towards 2-ketoisovalerate.
All measurements were performed in triplicate.
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NADPH as substrates (Figure 7). However, the optimum
temperature and pH of oxidative reaction were found to
be 40°C and 8.5 respectively (not shown).
Effect of metal ions on KivRFp
The effects of metal ions and ethylenediamine tetraacetic
acid (EDTA) on the KivRFp reductase activity were
investigated by measuring the residual enzyme activity in
their presence and depicted in Table 2. Among metal
ions tested, the reductase activity was increased by Mg2+



















Figure 6 Apparent temperature optimum of ketoisovalerate reductas
temperatures by purified KivRFp. The activity was determined at different t
at 35°C was set as 100%. All measurements were performed in triplicate.(123%). Furthermore, the reduction activity was inhibited
by Fe2+ and Co2+, moreover, almost totally inhibited by
Cu2+, Mn2+, Zn,
2+ and Fe3+ ( from 3% to 9% residual ac-
tivity respectively), while the chelating agent EDTA had
little effect, suggesting Mg2+ and Ca2+ are not determin-
ing factors, though they could promote the reductase
enzyme activity.
Effect of detergents and enzyme inhibitors on KivRFp
The effects of detergents and enzyme inhibitors on
ketoisovalerate reductase (KIVR) reduction activity are
shown in Table 3. A significant increase in reductive50 60 70
erature, OC
e KivRFp. Relative activity of ketoisovalerate reduction at different
emperatures at pH 8.0 in 50 mM sodium phosphate buffer. The activity









 50 mM Phosphate Buffer










Figure 7 Effect of pH on the purified ketoisovalerate reductase KivRFp. Relative activity of ketoisovalerate reduction was performed in
various pH buffers at 35°C (pH 5.0-8.0, 50 mM sodium phosphate buffer; pH 8.0-10.5, 50 mM Tris–HCl buffer). The activity at pH 7.5 was set as
100%. All measurements were performed in triplicate.
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(127%), Tween-80 (176%), DEPC (114%), and Tween-20
(129%), after 0.5 h preincubation with detergents at
37°C, which might help the substrate interaction with
the catalytic triad. Moreover, 0.5% β-mercaptoethanol
did not affect the reductive activity (102%), whereas
CTAB, PMSF, Triton X-100, and SDS strongly inhibited
enzymatic activity of KivRFp. The activity inhibition of
KivRFp by PMSF suggests that serine is involved in the
catalytic center, since PMSF could mimic the first transi-
tion state in ester bond hydrolysis presumably by link-
ing to the hydroxyl group of serine in the active site
covalently. The enzymatic activity of KivRFp is totallyTable 2 Effect of metal ions on esterase activity
Compounds Concentration (mM) Relative activity (%)
Control 0 100.0 ± 1.7
CoCl2 5 16.4 ± 2.9
K2SO4 5 123.2 ± 3.4
FeSO4 5 4.9 ± 1.6
CuCl2 5 7.8 ± 2.7
MnCl2 5 6.2 ± 1.3
EDTA 5 87.7 ± 3.2
FeCl3 5 7.9 ± 3.4
CaCl2 5 169.1 ± 3.7
ZnCl2 5 3.7 ± 1.8
MgCl2 5 195.6 ± 2.7
Activity without metal ions was set as 100%. All measurements were repeated
three times.inhibited by ionic detergent and the probable reasons
for these are ionic detergents such as SDS inhibits
both inter- and intra-molecular protein-protein
interaction.
Discussion
Ketoisovalerate reductases are types of oxidoreductases
which are widely distributed from prokaryotes to
eukaryotes and which are involved in primary and
second metabolism [17,20,34-36]. 2-hydroxyisovalerate
is a common 2-hydroxycarboxylate constituent of dep-
sipeptides. Reduction of Kiv in fungi provides Hiv, a
precursor for the biosynthesis of nonribosomalTable 3 Effect of detergents and enzyme inhibitors on
esterase activity
Compounds Concentration Relative activity (%)
Control 0 100.0 ± 2.1
DTT 3 mM 126.9 ± 4.9
CTAB 3 mM 42.7 ± 2.2
DEPC 3 mM 113.6 ± 2.7
PMSF 3 mM 53.6 ± 4.1
SDS 3 mM 6.3 ± 1.9
β-mercaptoethanol 0.5% 101.7 ± 2.6
Triton X-100 0.5% 60.8 ± 4.6
Tween-80 0.5% 176.4 ± 2.1
Tween-20 0.5% 128.7 ± 3.3
Activity without detergents and enzyme inhibitors was set as 100%.
All measurements were repeated three times.
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gomer depsipeptides synthetase A domains incorporate
free 2-hydroxycarboxylate precursors for the synthesis
of CODs, preformed by dissociated, independent,
monofunctional, NADPH-dependent enzymes with
high chiral specificity, exemplified by the D-Hiv de-
hydrogenase purified from the enniatin producer F. sam-
bucinum (teleomorph: G. pulicaris) [17,19]. In contrast,
known bacterial depsipeptide synthetases employ A
domains that activate and load 2-ketocarboxylates as β-
ketoacyl thioesters onto their cognate T domains, and
utilize integrated ketoacyl reductase domains for the
synthesis of 2-hydroxycarboxylate thioesters. This
might suggest the biosynthesis of 2-hydroxycarboxylate
precursors in bacteria and fungi may represent ex-
ample of convergent evolution [20]. This enzyme,
which plays a key role in beauvericin biosynthesis, cat-
alyzes the reversible reaction of 2-Kiv to D-Hiv using
NAD(P)H as a cofactor. 2-ketoisovalerate reductase
differs from other NADPH-dependent oxidoreductases
with broad substrate specificity by its high affinity for 2-
Kiv (Figure 5A). The high specificity of KivRFp may also
explain the fact that D-Hiv is the exclusive hydroxy acid
component in beauvericin isolated from Fusaria
(Logrieco A et al., 1998). To our knowledge this is the
first report about the heterologous production of a
ketoisovalerate reductase with higher substrate specificity
for 2-Kiv.
KivRFp, which was cloned, expressed, and purified,
was subjected to molecular and biochemical experiments
in this study. The F. proliferatum KivRFp exhibits high
amino acid sequence similarity to B. bassiana KIVR and
deduced dehydropantoate reductases of fungi, together
with low but significant sequence similarity predicted
secondary structure to prokaryotic ketopantoate reduc-
tases such as PanE of E. coli [20,30,31,36]. KivRFp and
the related B. bassiana KIVR are predicted to share the
N-terminal αβ-Rossmann fold and the C-terminal
α-helical catalytic domain architecture of the E. coli keto-
pantoate reductase. In the amino acid sequence of
KivRFp, the conserved catalytic triad (Glu-Asn-Lys) and
substrates stabilization active amino acids of ketonate
oxidoreductases are still the same. In ketopantoate re-
ductase PanE from E. coli, the protonated Lys176
(KivRFp: Lys285, Figure 2) could function as a general
acid to polarize the carbonyl in the direction of keto-
pantoate reduction, facilitates the hydride transfer from
NADPH to the C2 carbonyl of ketopantoate, and proto-
nates the intermediate alkoxide [20,31]. Asn98 (KivRFp:
Asn184) forms hydrogen binding both with the carboxyl-
ate of the ketopantoate and with the ribose of the nico-
tinamide: this orients the cofactor. And also, Glu256
(KivRFp: Glu405) and Lys72 (KivRFp: Lys158) further
participate substrate binding to the NADPH [20]. Furtherstabilization is provided by a hydrogen bond between the
Ser244 (KivRFp: Ser393) and carboxyl group of the keto-
pantoate, and between Asn180 (KivRFp: Asn289) and the
a-hydroxy group of the product. And also, KivRFp showed
sequence and the structural similarity with ketopantoate
reductases, but not with D-lactose or D-hydroxyisocaproate
dehydrogenase [20]. Further biochemical assay demon-
strated that Fusarium KivRFp could utilize NADPH and
NADH as coenzyme, while the NADPH is preferred
(Figure 5B). In accordance to our results, bacterial
chiral enzymes belonging to the D-ketoacid reductases
superfamily also could utilize NADH as coenzyme,
and also feature a conserved Arg-(Asp/Glu)-His active
site triad [20,37]. Based on the phylogenetic, molecu-
lar, and biochemical analysis results, we propose that
KivRFp is a new member of family ketonate oxidore-
ductases. Future work will establish the structure of this
enzyme to gain more information about its catalytic
mechanism.
Conclusion
In conclusion, we identified a new ketoisovalerate reduc-
tase KivRFp from the depsipeptide-producing fungus
F. proliferatum. KivRFp is expected to show high potential
for downstream biotechnological applications including
synthetic organic chemistry and combinatorial biosyn-
thesis beauvericin homologues. This was confirmed by its
extensive biochemical characterization, which revealed the
enzymes substrate specificity, wide pH and temperature
spectra, and also, stability towards addictives including
metal ions and detergents. Enlargement of the ketoisovale-
rate reductase pool can be an immediate source of genetic
modification, or yield enzymes that can be further specia-
lized by directed evolution, and also, this would optimize
their industrial applications.
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